Featured Research

from universities, journals, and other organizations

Researchers Successfully Test New Drug To Treat Acquired Haemophilia

Date:
July 21, 2006
Source:
Universitat Autonoma De Barcelona
Summary:
Researchers at the Universitat Autonoma de Barcelona Teaching Unit at Vall d'Hebron Hospital have developed a therapy to treat acquired haemophilia A. The therapy is based on the use of cyclosporin, which produces less side effects than the usual treatment based on using corticosteroids.

Researchers at the Universitat Autònoma de Barcelona Teaching Unit at Vall d'Hebron Hospital have developed a therapy to treat acquired haemophilia A. The therapy is based on the use of cyclosporin, which produces less side effects than the usual treatment based on using corticosteroids.

Related Articles


Acquired haemophilia A is an extremely rare disease that causes the sudden appearance of antibodies against coagulation factor VIII. This is therefore an autoimmune disease. This autoantibody, or inhibitor, impedes the activity of the factor VIII that collaborates in the normal coagulation cascade, meaning the patients have various haemorrhages in different parts of the body, especially on the skin, muscles and mucosae, which can be serious or life-threatening (the mortality rate without treatment is 30%).

The immunosuppressive treatments used to eradicate these autoantibodies are based mainly on using only corticosteroids or by combining corticosteroids with cytotoxic drugs (cyclophosphamide, vincristine, azathioprine). With cytotoxic drugs, however, there are many hematological or infectious side effects.

The UAB researchers have studied a more specific immunosuppressive therapy that has fewer side effects and is more tolerated by patients. They chose to use cyclosporin, which fits this pharmacological profile and had already been effective in a few cases of acquired haemophilia that did not improve when the traditional treatments were used.

From March 2001 to October 2003, five patients at Vall d'Hebron Hospital with acquired haemophilia were assessed. As soon as they were diagnosed they were treated with oral cyclosporin (3 to 5 mg/kg/day) and a daily intravenous infusion of corticosteroids (methylprednisolone 1g/day) over a period of three days. On day four, the treatment was changed to oral corticosteroids (prednisone 1mg/kg/day).

Cyclosporin and prednisone continued to be used until there was complete remission of the disease, ie, the complete disappearance of autoantibodies against coagulation factor VIII. Complete remission, with the disappearance of the inhibitor, was achieved for all patients after an average of four weeks from the start of the treatment.

Cyclosporin tolerance was good in all patients. Only one unusual neurological side effect was observed in one patient, but this quickly disappeared once the drug was no longer administered. In two years, no reappearance of the disease has been observed.

The researchers believe their study shows that it is probably beneficial to treat the disease first using cyclosporin associated with corticosteroids. This therapeutical option should be assessed in future studies.


Story Source:

The above story is based on materials provided by Universitat Autonoma De Barcelona. Note: Materials may be edited for content and length.


Cite This Page:

Universitat Autonoma De Barcelona. "Researchers Successfully Test New Drug To Treat Acquired Haemophilia." ScienceDaily. ScienceDaily, 21 July 2006. <www.sciencedaily.com/releases/2006/07/060721175524.htm>.
Universitat Autonoma De Barcelona. (2006, July 21). Researchers Successfully Test New Drug To Treat Acquired Haemophilia. ScienceDaily. Retrieved January 31, 2015 from www.sciencedaily.com/releases/2006/07/060721175524.htm
Universitat Autonoma De Barcelona. "Researchers Successfully Test New Drug To Treat Acquired Haemophilia." ScienceDaily. www.sciencedaily.com/releases/2006/07/060721175524.htm (accessed January 31, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Saturday, January 31, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC: Get Vaccinated for Measles

CDC: Get Vaccinated for Measles

Reuters - US Online Video (Jan. 30, 2015) — The CDC is urging people to get vaccinated for measles amid an outbreak that began at Disneyland and has now infected more than 90 people. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Obama To Outline New Plan For Personalized Medicine

Obama To Outline New Plan For Personalized Medicine

Newsy (Jan. 30, 2015) — President Obama is expected to speak with drugmakers Friday about his Precision Medicine Initiative first introduced last week. Video provided by Newsy
Powered by NewsLook.com
NFL Concussions Down; Still on Parents' Minds

NFL Concussions Down; Still on Parents' Minds

AP (Jan. 30, 2015) — The NFL announced this week that the number of game concussions dropped by a quarter over last season. Still, the dangers of the sport still weigh on players, and parents&apos; minds. (Jan. 30) Video provided by AP
Powered by NewsLook.com
U.S. Wants to Analyze DNA from 1 Million People

U.S. Wants to Analyze DNA from 1 Million People

Reuters - US Online Video (Jan. 30, 2015) — The U.S. has proposed analyzing genetic information from more than 1 million American volunteers to learn how genetic variants affect health and disease. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins